Trial Profile
Evaluation of Therapeutic Effect and Safety of RU-486 in the Treatment of Adenomyosis and Endometriosis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Aug 2020
Price :
$35
*
At a glance
- Drugs Mifepristone (Primary)
- Indications Adenomyosis; Endometriosis
- Focus Therapeutic Use
- 09 Apr 2018 New trial record